Gallium(III) triflate complex (Ga(OTf)3 complex)

Gallium(III) triflate complexes, such as the specific derivative Ga3, are coordination compounds currently being investigated as potent therapeutic agents rather than biological targets. These complexes function as iron(III) mimetics, exploiting the high iron requirements of malignant cells and pathogens to disrupt essential metabolic pathways. By binding to transferrin, they are selectively internalized by cells expressing high levels of the transferrin receptor (TfR1). Once inside the cell, the gallium ions inhibit ribonucleotide reductase, an enzyme critical for DNA synthesis, and interfere with mitochondrial electron transport. Recent research has demonstrated that specific gallium triflate-derived complexes can induce ferroptosis, a form of regulated cell death, making them promising candidates for treating breast cancer and other solid tumors. While gallium nitrate is already used clinically for hypercalcemia, these newer complexes aim to provide better bioavailability and reduced toxicity.

Other names

Ga3Gallium triflateGallium(III) trifluoromethanesulfonate complexGa(OTf)3Gallium heteroscorpionate complex

Gallium(III) complexes act as iron(III) mimetics, exploiting the similar ionic radius and coordination geometry of Ga3+ and Fe3+. They compete for iron-binding sites on transferrin for cellular uptake via the transferrin receptor (TfR1). Once internalized, gallium disrupts iron-dependent processes by inhibiting ribonucleotide reductase (RNR), interfering with mitochondrial electron transport, and inducing oxidative stress or ferroptosis, ultimately leading to cell death in rapidly proliferating cells.